Impact of a Novel Immune Modulating Dietary Supplement on House Dust Mite Induced Allergic Rhinoconjunctivitis
Condition(s):Allergic Rhinoconjunctivitis Due to House Dust Mite AllergensLast Updated:July 20, 2020Active, not recruiting
Hide Studies Not Open or Pending
Condition(s):Allergic Rhinoconjunctivitis Due to House Dust Mite AllergensLast Updated:July 20, 2020Active, not recruiting
Condition(s):Asthma; AtopyLast Updated:November 22, 2017Completed
Condition(s):AsthmaLast Updated:November 3, 2005Unknown status
Condition(s):Allergen Immunotherapy, Immunological Mechanisms,Monosensitized,Polysensitized,Clinical EfficacyLast Updated:March 1, 2013Unknown status
Condition(s):Allergic RhinitisLast Updated:November 24, 2010Completed
Condition(s):Asthma; AllergiesLast Updated:September 15, 2017Completed
Condition(s):AsthmaLast Updated:February 25, 2021Recruiting
Condition(s):Asthma, AllergicLast Updated:April 2, 2020Enrolling by invitation
Condition(s):HypersensitivityLast Updated:June 26, 2015Completed
Condition(s):Asthma; AllergiesLast Updated:September 15, 2017Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.